{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:45:17Z","timestamp":1792269917350,"version":"4.4.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T00:00:00Z","timestamp":1174348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1742-4933-4-1","type":"journal-article","created":{"date-parts":[[2007,5,2]],"date-time":"2007-05-02T15:36:06Z","timestamp":1178120166000},"source":"Crossref","is-referenced-by-count":76,"title":["The Interleukin-6 inflammation pathway from cholesterol to aging \u2013 Role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases"],"prefix":"10.1186","volume":"4","author":[{"given":"Sota","family":"Omoigui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,20]]},"reference":[{"key":"36_CR1","doi-asserted-by":"crossref","unstructured":"Huang H, Patel DD, Manton KG: The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci. 10: 192-215. 2005 Jan 1; Print 2005 Jan 1","DOI":"10.2741\/1521"},{"key":"36_CR2","doi-asserted-by":"crossref","unstructured":"Hackam DG, Anand SS: Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 290 (7): 932-40. 10.1001\/jama.290.7.932. 2003 Aug 20","DOI":"10.1001\/jama.290.7.932"},{"key":"36_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R: Atherosclerosis an inflammatory disease. N Engl J Med. 1999, 340: 115-26. 10.1056\/NEJM199901143400207.","journal-title":"N Engl J Med"},{"key":"36_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maser A: Inflammation and atherosclerosis. Circulation. 2002, 105: 1135-43. 10.1161\/hc0902.104353.","journal-title":"Circulation"},{"key":"36_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1146\/annurev.ph.57.030195.004043","volume":"57","author":"R Ross","year":"1995","unstructured":"Ross R: Cell biology of atherosclerosis. Annu Rev Physiol. 1995, 57: 791-804. 10.1146\/annurev.ph.57.030195.004043.","journal-title":"Annu Rev Physiol"},{"key":"36_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1050-1738(97)00086-8","volume":"7","author":"I Tabas","year":"1997","unstructured":"Tabas I: Free cholesterol-induced cytotoxicity. A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions. Trends Cardiovasc Med. 1997, 7: 256-263. 10.1016\/S1050-1738(97)00086-8.","journal-title":"Trends Cardiovasc Med"},{"key":"36_CR7","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/01.ATV.18.10.1519","volume":"18","author":"MM Kockx","year":"1998","unstructured":"Kockx MM: Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol. 1998, 18: 1519-1522.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"36_CR8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00041433-199610000-00011","volume":"7","author":"MJ Mitchinson","year":"1996","unstructured":"Mitchinson MJ, Hardwick SJ, Bennett MR: Cell death in atherosclerotic plaques. Curr Opin Lipidol. 1996, 7: 324-329.","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"36_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","volume":"24","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Lerman LO, Napoli C, Lerman A: Statin effects beyond lipid lowering \u2013 are they clinically relevant?. Eur Heart J. 2003, 24 (3): 225-48. 10.1016\/S0195-668X(02)00419-0.","journal-title":"Eur Heart J"},{"issue":"1 Pt 2","key":"36_CR10","first-page":"101","volume":"62","author":"J Davignon","year":"2001","unstructured":"Davignon J, Mabile L: Mechanisms of action of statins and their pleiotropic effects [Article in French]. Ann Endocrinol (Paris). 2001, 62 (1 Pt 2): 101-12.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"36_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/ENDO:23:1:01","volume":"23","author":"SI McFarlane","year":"2004","unstructured":"McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR: Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?. Endocrine. 2004, 23 (1): 1-10. 10.1385\/ENDO:23:1:01.","journal-title":"Endocrine"},{"key":"36_CR12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","volume":"265","author":"PC Heinrich","year":"1990","unstructured":"Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J. 1990, 265: 621-636.","journal-title":"Biochem J"},{"key":"36_CR13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.94.5.874","volume":"94","author":"LM Biasucci","year":"1996","unstructured":"Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A: Elevated levels of interleukin-6 in unstable angina. Circulation. 1996, 94: 874-877.","journal-title":"Circulation"},{"key":"36_CR14","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/01.CIR.99.16.2079","volume":"99","author":"LM Biasucci","year":"1999","unstructured":"Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi Ag, Ginnetti F, Dinarello CA, Maseri A: Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increasing risk of in-hospital coronary events. Circulation. 1999, 99: 2079-2084.","journal-title":"Circulation"},{"key":"36_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF01983484","volume":"42","author":"Z Szekanecz","year":"1994","unstructured":"Szekanecz Z, Shah MR, Pearce WH, Koch AE: Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions. 1994, 42: 159-162. 10.1007\/BF01983484.","journal-title":"Agents Actions"},{"key":"36_CR16","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","volume":"101","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Rifai N, Pfeifer M, Sacks F, Lepage S, Braunwald E: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000, 101: 2149-2153.","journal-title":"Circulation"},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","volume":"101","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000, 101: 1767-1772.","journal-title":"Circulation"},{"key":"36_CR18","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0735-1097(99)00007-8","volume":"33","author":"J Ma","year":"1999","unstructured":"Ma J, Hennekens CH, Ridker PM, Stampfer MJ: A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. J Am Coll Cardiol. 1999, 33: 1347-1352. 10.1016\/S0735-1097(99)00007-8.","journal-title":"J Am Coll Cardiol"},{"key":"36_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0002-9149(90)90079-G","volume":"65","author":"BC Berk","year":"1990","unstructured":"Berk BC, Weintraub WS, Alexander RW: Elevation of C-reactive protein in \"active\" coronary artery disease. Am J Cardiol. 1990, 65: 168-172. 10.1016\/0002-9149(90)90079-G.","journal-title":"Am J Cardiol"},{"key":"36_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0895-4356(99)00143-2","volume":"53","author":"ES Ford","year":"2000","unstructured":"Ford ES, Giles WH: Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III. J Clin Epidemiol. 2000, 53: 95-102. 10.1016\/S0895-4356(99)00143-2.","journal-title":"J Clin Epidemiol"},{"key":"36_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0025-7125(05)70211-X","volume":"84","author":"DA Morrow","year":"2000","unstructured":"Morrow DA, Ridker PM: C-reactive protein, inflammation, and coronary risk. Med Clin North Am. 2000, 84: 149-161. 10.1016\/S0025-7125(05)70211-X.","journal-title":"Med Clin North Am"},{"key":"36_CR22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","volume":"100","author":"PM Ridker","year":"1999","unstructured":"Ridker PM, Rifai N, Pfeifer MA, Sacks F, Braunwald E: Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1999, 100: 230-235.","journal-title":"Circulation"},{"key":"36_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S1047-2797(98)00049-0","volume":"9","author":"DA Schaumberg","year":"1999","unstructured":"Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR, Hennekens CH: High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol. 1999, 9: 166-171. 10.1016\/S1047-2797(98)00049-0.","journal-title":"Ann Epidemiol"},{"key":"36_CR24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","volume":"97","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998, 97: 425-428.","journal-title":"Circulation"},{"key":"36_CR25","doi-asserted-by":"crossref","unstructured":"Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M: Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 108 (19): 2317-22. 10.1161\/01.CIR.0000097109.90783.FC. 2003 Nov 11","DOI":"10.1161\/01.CIR.0000097109.90783.FC"},{"key":"36_CR26","unstructured":"King MW: Medical Biochemistry Course Guide, 2004. Cholesterol and Bile Metabolism. Indiana University School of Medicine"},{"key":"36_CR27","doi-asserted-by":"crossref","unstructured":"Zhao L, Hart S, Cheng J, Melenhorst JJ, Bierie B, Ernst M, Stewart C, Schaper F, Heinrich PC, Ullrich A, Robinson GW, Hennighausen L: Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK. J Biol Chem. 279 (42): 44093-100. 10.1074\/jbc.M313131200. 2004 Oct 15;. Epub 2004 Jul 30","DOI":"10.1074\/jbc.M313131200"},{"key":"36_CR28","doi-asserted-by":"crossref","unstructured":"Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Tracy RP, Rubin SM, Harris TB, Pahor M: Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am J Cardiol. 92 (5): 522-8. 10.1016\/S0002-9149(03)00718-5. 2003 Sep 1","DOI":"10.1016\/S0002-9149(03)00718-5"},{"key":"36_CR29","doi-asserted-by":"crossref","unstructured":"Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T: Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 61 (1): 76-80. 2003 Jul 8","DOI":"10.1212\/01.WNL.0000073620.42047.D7"},{"key":"36_CR30","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.144.11.4226","volume":"144","author":"N Kurihara","year":"1990","unstructured":"Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD: IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol. 1990, 144: 4226-4230.","journal-title":"J Immunol"},{"key":"36_CR31","doi-asserted-by":"publisher","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","volume":"90","author":"T Tamura","year":"1993","unstructured":"Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T: Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA. 1993, 90: 11924-11928. 10.1073\/pnas.90.24.11924.","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR32","doi-asserted-by":"crossref","unstructured":"Manolagas SC, Jilka RL: Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 332 (5): 305-11. 10.1056\/NEJM199502023320506. 1995 Feb 2","DOI":"10.1056\/NEJM199502023320506"},{"key":"36_CR33","doi-asserted-by":"crossref","unstructured":"Yoshii T, Magara S, Miyai D, Nishimura H, Kuroki E, Furudoi S, Komori T, Ohbayashi C: Local levels of interleukin-1beta, -4, -6 and tumor necrosis factor alpha in an experimental model of murine osteomyelitis due to staphylococcus aureus. Cytokine. 19 (2): 59-65. 10.1006\/cyto.2002.1039. 2002 Jul 21","DOI":"10.1006\/cyto.2002.1039"},{"issue":"10","key":"36_CR34","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/rheumatology\/37.10.1095","volume":"37","author":"S Meghji","year":"1998","unstructured":"Meghji S, Crean SJ, Hill PA, Sheikh M, Nair SP, Heron K, Henderson B, Mawer EB, Harris M: Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology. Br J Rheumatol. 1998, 37 (10): 1095-101. 10.1093\/rheumatology\/37.10.1095.","journal-title":"Br J Rheumatol"},{"issue":"5","key":"36_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-3083.1998.00318.x","volume":"47","author":"H Hotokezaka","year":"1998","unstructured":"Hotokezaka H, Kitamura A, Matsumoto S, Hanazawa S, Amano S, Yamada T: Internalization of Mycobacterium bovis Bacillus Calmette-Guerin into osteoblast-like MC3T3-E1 cells and bone resorptive responses of the cells against the infection. Scand J Immunol. 1998, 47 (5): 453-8. 10.1046\/j.1365-3083.1998.00318.x.","journal-title":"Scand J Immunol"},{"key":"36_CR36","doi-asserted-by":"crossref","unstructured":"Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R: Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA. 100 (15): 9090-5. 10.1073\/pnas.1531903100. 2003 Jul 22; Epub 2003 Jul 2","DOI":"10.1073\/pnas.1531903100"},{"issue":"9","key":"36_CR37","doi-asserted-by":"crossref","first-page":"M434","DOI":"10.1093\/gerona\/54.9.M434","volume":"54","author":"SK Lutgendorf","year":"1999","unstructured":"Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM: Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci. 1999, 54 (9): M434-9.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"36_CR38","doi-asserted-by":"crossref","unstructured":"Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway. Biochem J. 334 (Pt 2): 297-314. 1998 Sep 1","DOI":"10.1042\/bj3340297"},{"issue":"5332","key":"36_CR39","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell Jr","year":"1997","unstructured":"Darnell JE: STATs and gene regulation. Science. 1997, 277 (5332): 1630-1635. 10.1126\/science.277.5332.1630.","journal-title":"Science"},{"issue":"4","key":"36_CR40","first-page":"321","volume":"47","author":"A Ogata","year":"1999","unstructured":"Ogata A, Nishimoto N, Yoshizaki K: Advances in interleukin-6 therapy. Rinsho Byori. 1999, 47 (4): 321-6.","journal-title":"Rinsho Byori"},{"issue":"4","key":"36_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1359-6101(98)80005-1","volume":"8","author":"T Hirano","year":"1997","unstructured":"Hirano T, Nakajima K, Hibi M: Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 1997, 8 (4): 241-52. 10.1016\/S1359-6101(98)80005-1.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"36_CR42","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/S1357-2725(97)00063-0","volume":"29","author":"S Akira","year":"1997","unstructured":"Akira S: IL-6-regulated transcription factors. Int J Biochem Cell Biol. 1997, 29 (12): 1401-18. 10.1016\/S1357-2725(97)00063-0.","journal-title":"Int J Biochem Cell Biol"},{"key":"36_CR43","doi-asserted-by":"crossref","first-page":"16483","DOI":"10.1074\/jbc.270.28.16483","volume":"270","author":"M Karin","year":"1995","unstructured":"Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995, 270: 16483-6.","journal-title":"J Biol Chem"},{"key":"36_CR44","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/0092-8674(86)90346-6","volume":"46","author":"R Sen","year":"1986","unstructured":"Sen R, Baltimore D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986, 46: 706-716. 10.1016\/0092-8674(86)90346-6.","journal-title":"Cell"},{"key":"36_CR45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1101\/gad.6.5.775","volume":"6","author":"T Fujita","year":"1992","unstructured":"Fujita T, Nolan GP, Ghosh S, Baltimore D: Independent modes of transcriptional activation by the p50 and p65 subunits of NF-\u03ba\u03b2. Genes Dev. 1992, 6: 775-787.","journal-title":"Genes Dev"},{"key":"36_CR46","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0092-8674(00)80222-6","volume":"89","author":"H Zhong","year":"1997","unstructured":"Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S: The transcriptional activity of NF-\u03ba\u03b2 is regulated by the I-\u03ba\u03b2-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 1997, 89: 413-424. 10.1016\/S0092-8674(00)80222-6.","journal-title":"Cell"},{"key":"36_CR47","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1101\/gad.9.22.2723","volume":"9","author":"I Verma","year":"1995","unstructured":"Verma I, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel\/NF\u03ba\u03b2\/I\u03ba\u03b2 family: intimate tales of association and dissociation. Genes Dev. 1995, 9: 2723-2735.","journal-title":"Genes Dev"},{"key":"36_CR48","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0092-8674(00)81064-8","volume":"84","author":"Z Chen","year":"1996","unstructured":"Chen Z, Parent L, Maniatis T: Site-specific phosphorylation of I\u03ba\u03b2\u03b1 by a novel ubiquitination-dependent pathway. Cell. 1996, 84: 853-862. 10.1016\/S0092-8674(00)81064-8.","journal-title":"Cell"},{"key":"36_CR49","first-page":"1130","volume":"18","author":"PA Baeuerle","year":"1994","unstructured":"Baeuerle PA, Henkel T: Function and activation of NF-\u03baB 1995 Rel\/NF T 1996 Site-specific phosphorylation of Iin vitro cell mediated immune assay predicts in vivo response. J Rheumatol. 1994, 18: 1130-1133.","journal-title":"J Rheumatol"},{"key":"36_CR50","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1101\/gad.9.22.2723","volume":"9","author":"I Verma","year":"1995","unstructured":"Verma I, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel\/NF\u03ba\u03b2\/I\u03ba\u03b2 family: intimate tales of association and dissociation. Genes Dev. 1995, 9: 2723-2735.","journal-title":"Genes Dev"},{"key":"36_CR51","doi-asserted-by":"crossref","unstructured":"Rothwarf DM, Zandi E, Natoli G, Karin M: IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature. 395 (6699): 297-300. 1998 Sep 17","DOI":"10.1038\/26261"},{"key":"36_CR52","doi-asserted-by":"publisher","first-page":"10599","DOI":"10.1073\/pnas.92.23.10599","volume":"92","author":"I Alkalay","year":"1995","unstructured":"Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y: Stimulation-dependent I\u03ba\u03b2\u03b1 phosphorylation marks the NF\u03ba\u03b2 inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1995, 92: 10599-10603. 10.1073\/pnas.92.23.10599.","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR53","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0092-8674(94)90482-0","volume":"78","author":"VJ Palombella","year":"1994","unstructured":"Palombella VJ, Rando OJ, Goldberg AL, Maniatis T: The ubiquitin-proteasome pathway is required for processing the NF-\u03ba\u03b21 precursor protein and the activation of NF-\u03ba\u03b2. Cell. 1994, 78: 773-785. 10.1016\/S0092-8674(94)90482-0.","journal-title":"Cell"},{"key":"36_CR54","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","volume":"14","author":"AS Baldwin","year":"1996","unstructured":"Baldwin AS: The NF\u03baB and I\u03baB proteins: new discoveries and insights. Annu Rev Immunol. 1996, 14: 649-681. 10.1146\/annurev.immunol.14.1.649.","journal-title":"Annu Rev Immunol"},{"key":"36_CR55","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1084\/jem.182.6.1951","volume":"182","author":"IM Adcock","year":"1995","unstructured":"Adcock IM, Lane SJ, Brown CR, Lee TH, Barnes PJ: Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med. 1995, 182: 1951-1958. 10.1084\/jem.182.6.1951.","journal-title":"J Exp Med"},{"issue":"1","key":"36_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/me.12.1.45","volume":"12","author":"LI McKay","year":"1998","unstructured":"McKay LI, Cidlowski JA: Cross-Talk between Nuclear Factor-\u03baB and the Steroid Hormone Receptors: Mechanisms of Mutual Antagonism. Molecular Endocrinology. 1998, 12 (1): 45-56. 10.1210\/me.12.1.45.","journal-title":"Molecular Endocrinology"},{"key":"36_CR57","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0092-8674(00)80222-6","volume":"89","author":"H Zhong","year":"1997","unstructured":"Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S: The transcriptional activity of NF-\u03ba\u03b2 is regulated by the I-\u03ba\u03b2-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 1997, 89: 413-424. 10.1016\/S0092-8674(00)80222-6.","journal-title":"Cell"},{"key":"36_CR58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu Rev Immunol. 2000, 18: 621-63. 10.1146\/annurev.immunol.18.1.621.","journal-title":"Annu Rev Immunol"},{"key":"36_CR59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","volume":"544","author":"W Vanden Berghe","year":"2003","unstructured":"Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G: A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv Exp Med Biol. 2003, 544: 181-96.","journal-title":"Adv Exp Med Biol"},{"key":"36_CR60","doi-asserted-by":"crossref","unstructured":"Han Y, Runge MS, Brasier AR: Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res. 84 (6): 695-703. 1999 Apr 2","DOI":"10.1161\/01.RES.84.6.695"},{"issue":"3","key":"36_CR61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1568010023344616","volume":"1","author":"A Cabrero","year":"2002","unstructured":"Cabrero A, Laguna JC, Vazquez M: Peroxisome proliferator-activated receptors and the control of inflammation. Curr Drug Targets Inflamm Allergy. 2002, 1 (3): 243-8. 10.2174\/1568010023344616.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"36_CR62","doi-asserted-by":"crossref","unstructured":"Neve BP, Fruchart JC, Staels B: Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol. 60 (8): 1245-50. 10.1016\/S0006-2952(00)00430-5. 2000 Oct 15","DOI":"10.1016\/S0006-2952(00)00430-5"},{"issue":"8","key":"36_CR63","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/1044549041562285","volume":"23","author":"KC Leung","year":"2004","unstructured":"Leung KC: Regulation of cytokine receptor signaling by nuclear hormone receptors: a new paradigm for receptor interaction. DNA Cell Biol. 2004, 23 (8): 463-74. 10.1089\/1044549041562285.","journal-title":"DNA Cell Biol"},{"key":"36_CR64","unstructured":"Das UN: Statins and the prevention of dementia. CMAJ. 165 (7): 908-909. OCT. 2, 2001"},{"issue":"1","key":"36_CR65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","volume":"81","author":"Y Takai","year":"2001","unstructured":"Takai Y, Sasaki T, Matozaki T: Small GTP-binding proteins. Physiol Rev. 2001, 81 (1): 153-208.","journal-title":"Physiol Rev"},{"key":"36_CR66","doi-asserted-by":"crossref","unstructured":"Wennerberg K, Rossman KL, Der CJ: The Ras superfamily at a glance. J Cell Sci. 118 (Pt 5): 843-6. 2005 Mar 1","DOI":"10.1242\/jcs.01660"},{"key":"36_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0092-8674(00)80601-7","volume":"98","author":"T Magee","year":"1999","unstructured":"Magee T, Marshall C: New insights into the interaction of Ras with the plasma membrane. Cell. 1999, 98: 9-12. 10.1016\/S0092-8674(00)80601-7.","journal-title":"Cell"},{"key":"36_CR68","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ndt\/17.3.349","volume":"17","author":"R Dechend","year":"2002","unstructured":"Dechend R, M\u00fcller D, Park JK, Fiebeler A, Haller H, Luft FC: Statins and angiotensin II-induced vascular injury. Nephrol Dial Transplant. 2002, 17: 349-353. 10.1093\/ndt\/17.3.349.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"36_CR69","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1200\/JCO.1999.17.3.1071","volume":"17","author":"DM Beaupre","year":"1999","unstructured":"Beaupre DM, Kurzrock R: RAS and leukemia: from basic mechanisms to gene-directed therapy. J Clin Oncol. 1999, 17 (3): 1071-9.","journal-title":"J Clin Oncol"},{"key":"36_CR70","doi-asserted-by":"crossref","unstructured":"Sano M, Fukuda K, Kodama H, Takahashi T, Kato T, Hakuno D, Sato T, Manabe T, Tahara S, Ogawa S: Autocrine\/Paracrine secretion of IL-6 family cytokines causes angiotensin II-induced delayed STAT3 activation. Biochem Biophys Res Commun. 269 (3): 798-802. 10.1006\/bbrc.2000.2364. 2000 Mar 24","DOI":"10.1006\/bbrc.2000.2364"},{"key":"36_CR71","doi-asserted-by":"crossref","unstructured":"Faruqi TR, Gomez D, Bustelo XR, Bar-Sagi D, Reich NC: Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci USA. 98 (16): 9014-9. 10.1073\/pnas.161281298. 2001 Jul 31; Epub 2001 Jul 24","DOI":"10.1073\/pnas.161281298"},{"issue":"10","key":"36_CR72","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1091\/mbc.12.10.3282","volume":"12","author":"S Aznar","year":"2001","unstructured":"Aznar S, Valeron PF, del Rincon SV, Perez LF, Perona R, Lacal JC: Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Mol Biol Cell. 2001, 12 (10): 3282-94.","journal-title":"Mol Biol Cell"},{"issue":"12","key":"36_CR73","first-page":"1948","volume":"7","author":"M Lubbert","year":"1993","unstructured":"Lubbert M, Oster W, Knopf HP, McCormick F, Mertelsmann R, Herrmann F: N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6. Leukemia. 1993, 7 (12): 1948-54.","journal-title":"Leukemia"},{"issue":"4","key":"36_CR74","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1128\/MCB.23.4.1316-1333.2003","volume":"23","author":"S Pelletier","year":"2003","unstructured":"Pelletier S, Duhamel F, Coulombe P, Popoff MR, Meloche S: Rho family GTPases are required for activation of Jak\/STAT signaling by G protein-coupled receptors. Mol Cell Biol. 2003, 23 (4): 1316-33. 10.1128\/MCB.23.4.1316-1333.2003.","journal-title":"Mol Cell Biol"},{"key":"36_CR75","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(99)08347-6","volume":"355","author":"A Khwaja","year":"2000","unstructured":"Khwaja A, O'Connolly J, Hendry BM: Prenylation inhibitors in renal disease. Lancet. 2000, 355: 741-744. 10.1016\/S0140-6736(99)08347-6.","journal-title":"Lancet"},{"key":"36_CR76","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.HYP.36.3.325","volume":"36","author":"U Ikeda","year":"2000","unstructured":"Ikeda U, Shimpo M, Ohki R, Inaba H, Takahashi M, Yamamoto K, Shimada K: Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells. Hypertension. 2000, 36: 325-329.","journal-title":"Hypertension"},{"key":"36_CR77","doi-asserted-by":"crossref","unstructured":"Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G: Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys. 373 (1): 231-41. 10.1006\/abbi.1999.1502. 2000 Jan 1","DOI":"10.1006\/abbi.1999.1502"},{"issue":"32","key":"36_CR78","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.2174\/1381612033453640","volume":"9","author":"MJ Rogers","year":"2003","unstructured":"Rogers MJ: New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des. 2003, 9 (32): 2643-58. 10.2174\/1381612033453640.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"36_CR79","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00253-002-0932-9","volume":"58","author":"M Manzoni","year":"2002","unstructured":"Manzoni M, Rollini M: Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl Microbiol Biotechnol. 2002, 58 (5): 555-64. 10.1007\/s00253-002-0932-9. Epub 2002 Feb 14","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"36_CR80","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","volume":"79","author":"C Manach","year":"2004","unstructured":"Manach C, Scalbert A, Morand C, Remesy C, Jimenez L: Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004, 79 (5): 727-47.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"36_CR81","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.34.1.118","volume":"34","author":"Y Funakoshi","year":"1999","unstructured":"Funakoshi Y, Ichiki T, Ito K, Takeshita A: Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension. 1999, 34 (1): 118-25.","journal-title":"Hypertension"},{"issue":"9","key":"36_CR82","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hq0901.095547","volume":"21","author":"S Keidar","year":"2001","unstructured":"Keidar S, Heinrich R, Kaplan M, Hayek T, Aviram M: Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6. Arterioscler Thromb Vasc Biol. 2001, 21 (9): 1464-9.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"36_CR83","doi-asserted-by":"crossref","unstructured":"Klouche M, Rose-John S, Schmiedt W, Bhakdi S: Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation. 101 (15): 1799-805. 2000 Apr 18","DOI":"10.1161\/01.CIR.101.15.1799"},{"key":"36_CR84","doi-asserted-by":"crossref","unstructured":"Klouche M, Bhakdi S, Hemmes M, Rose-John S: Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. J Immunol. 163 (8): 4583-9. 1999 Oct 15","DOI":"10.4049\/jimmunol.163.8.4583"},{"issue":"3","key":"36_CR85","first-page":"445","volume":"20","author":"T Nabata","year":"1990","unstructured":"Nabata T, Morimoto S, Koh E, Shiraishi T, Ogihara T: Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem Int. 1990, 20 (3): 445-53.","journal-title":"Biochem Int"},{"issue":"1","key":"36_CR86","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/1043-4666(94)90013-2","volume":"6","author":"Y Seino","year":"1994","unstructured":"Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K: Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine. 1994, 6 (1): 87-91. 10.1016\/1043-4666(94)90013-2.","journal-title":"Cytokine"},{"issue":"11","key":"36_CR87","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/hq1101.098489","volume":"21","author":"T Tokunou","year":"2001","unstructured":"Tokunou T, Ichiki T, Takeda K, Funakoshi Y, Iino N, Shimokawa H, Egashira K, Takeshita A: Thrombin induces interleukin-6 expression through the cAMP response element in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001, 21 (11): 1759-63.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"36_CR88","first-page":"160","volume":"167","author":"N Williams","year":"1992","unstructured":"Williams N, Bertoncello I, Jackson H, Arnold J, Kavnoudias H: The role of interleukin 6 in megakaryocyte formation, megakaryocyte development and platelet production. Ciba Found Symp. 1992, 167: 160-170. discussion 170\u2013173","journal-title":"Ciba Found Symp"},{"key":"36_CR89","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-0038-1648857","volume":"72","author":"L Oleksowicz","year":"1994","unstructured":"Oleksowicz L, Mrowiec Z, Zuckerman D, Isaacs R, Dutcher J, Puszkin E: Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism. Thromb Haemost. 1994, 72: 302-308.","journal-title":"Thromb Haemost"},{"key":"36_CR90","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/stem.5530120405","volume":"12","author":"SA Burstein","year":"1994","unstructured":"Burstein SA: Effects of interleukin 6 on megakaryocytes and on canine platelet function. Stem Cells. 1994, 12: 386-393.","journal-title":"Stem Cells"},{"issue":"4","key":"36_CR91","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000079706","volume":"24","author":"S Watanabe","year":"2004","unstructured":"Watanabe S, Mu W, Kahn A, Jing N, Li JH, Lan HY, Nakagawa T, Ohashi R, Johnson RJ: Role of JAK\/STAT pathway in IL-6-induced activation of vascular smooth muscle cells. Am J Nephrol. 2004, 24 (4): 387-92. 10.1159\/000079706. Epub 2004 Jul 9","journal-title":"Am J Nephrol"},{"issue":"3\u20134","key":"36_CR92","first-page":"241","volume":"109","author":"B Okopien","year":"2001","unstructured":"Okopien B, Hyper M, Kowalski J, Belowski D, Madej A, Zielinski M, Tokarz D, Kalina Z, Herman ZS: A new immunological marker of atherosclerotic injury of arterial wall. Res Commun Mol Pathol Pharmacol. 2001, 109 (3\u20134): 241-8.","journal-title":"Res Commun Mol Pathol Pharmacol"},{"issue":"2","key":"36_CR93","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0021-9150(03)00193-X","volume":"169","author":"H Nawawi","year":"2003","unstructured":"Nawawi H, Osman NS, Annuar R, Khalid BA, Yusoff K: Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin. Atherosclerosis. 2003, 169 (2): 283-91. 10.1016\/S0021-9150(03)00193-X.","journal-title":"Atherosclerosis"},{"issue":"6","key":"36_CR94","doi-asserted-by":"crossref","first-page":"130","DOI":"10.18773\/austprescr.2000.144","volume":"23","author":"TJ Martin","year":"2000","unstructured":"Martin TJ, Grill V: Experimental and clinical pharmacology: bisphosphonates-mechanisms of action. Aust Prescriber. 2000, 23 (6): 130-2.","journal-title":"Aust Prescriber"},{"key":"36_CR95","unstructured":"Wuster C, Heilmann P: [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate]. Fortschr Med. 115 (29): 37-42. 1997 Oct 20"},{"issue":"3","key":"36_CR96","first-page":"359","volume":"20","author":"D Rendina","year":"2002","unstructured":"Rendina D, Postiglione L, Vuotto P, Numis FG, Di Domenico G, Viceconti R, Mossetti G, Nunziata V: Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone. Clin Exp Rheumatol. 2002, 20 (3): 359-64.","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"36_CR97","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1358\/mf.1999.21.8.794832","volume":"21","author":"JM Olmos","year":"1999","unstructured":"Olmos JM, De Vega T, Perera L, Riancho JA, Amado JA, Gonzalez-Macias J: Etidronate inhibits the production of IL-6 by osteoblast-like cells. Methods Find Exp Clin Pharmacol. 1999, 21 (8): 519-22. 10.1358\/mf.1999.21.8.794832.","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"1","key":"36_CR98","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/030097498441155","volume":"27","author":"N Giuliani","year":"1998","unstructured":"Giuliani N, Pedrazzoni M, Passeri G, Girasole G: Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scand J Rheumatol. 1998, 27 (1): 38-41. 10.1080\/030097498441155.","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"36_CR99","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1210\/en.137.6.2324","volume":"137","author":"C Vitte","year":"1996","unstructured":"Vitte C, Fleisch H, Guenther HL: Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology. 1996, 137 (6): 2324-33. 10.1210\/en.137.6.2324.","journal-title":"Endocrinology"},{"issue":"10","key":"36_CR100","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","volume":"104","author":"LI Plotkin","year":"1999","unstructured":"Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T: Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999, 104 (10): 1363-74.","journal-title":"J Clin Invest"},{"issue":"2","key":"36_CR101","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0609.1998.tb01073.x","volume":"61","author":"N Abildgaard","year":"1998","unstructured":"Abildgaard N, Rungby J, Glerup H, Brixen K, Kassem M, Brincker H, Heickendorff L, Eriksen EF, Nielsen JL: Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma. Eur J Haematol. 1998, 61 (2): 128-34.","journal-title":"Eur J Haematol"},{"issue":"6","key":"36_CR102","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0955-2863(03)00056-1","volume":"14","author":"X Chen","year":"2003","unstructured":"Chen X, Garner SC, Quarles LD, Anderson JJ: Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation. J Nutr Biochem. 2003, 14 (6): 342-9. 10.1016\/S0955-2863(03)00056-1.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"36_CR103","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF02976960","volume":"26","author":"BH Kim","year":"2003","unstructured":"Kim BH, Chung EY, Ryu JC, Jung SH, Min KR, Kim Y: Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response. Arch Pharm Res. 2003, 26 (4): 306-11.","journal-title":"Arch Pharm Res"},{"issue":"2","key":"36_CR104","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0031-9422(03)00101-8","volume":"63","author":"KS Suh","year":"2003","unstructured":"Suh KS, Koh G, Park CY, Woo JT, Kim SW, Kim JW, Park IK, Kim YS: Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry. 2003, 63 (2): 209-15. 10.1016\/S0031-9422(03)00101-8.","journal-title":"Phytochemistry"},{"key":"36_CR105","doi-asserted-by":"crossref","unstructured":"Borsellino N, Bonavida B, Ciliberto G, Toniatti C, Travali S, D'Alessandro N: Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity. Cancer. 85 (1): 134-44. 10.1002\/(SICI)1097-0142(19990101)85:1<134::AID-CNCR19>3.0.CO;2-C. 1999 Jan 1","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<134::AID-CNCR19>3.0.CO;2-C"},{"issue":"7","key":"36_CR106","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1210\/jc.82.7.2143","volume":"82","author":"TH Jones","year":"1997","unstructured":"Jones TH, Justice SK, Price A: Suppression of tyrosine kinase activity inhibits [3H]thymidine uptake in cultured human pituitary tumor cells. J Clin Endocrinol Metab. 1997, 82 (7): 2143-7. 10.1210\/jc.82.7.2143.","journal-title":"J Clin Endocrinol Metab"},{"key":"36_CR107","doi-asserted-by":"crossref","unstructured":"Geng Y, Zhang B, Lotz M: Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol. 151 (12): 6692-700. 1993 Dec 15","DOI":"10.4049\/jimmunol.151.12.6692"},{"key":"36_CR108","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0006-2952(99)00112-4","volume":"58","author":"JK Lin","year":"1999","unstructured":"Lin JK, Liang YC, Lin-Shiau SY: Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol. 1999, 58: 911-5. 10.1016\/S0006-2952(99)00112-4.","journal-title":"Biochem Pharmacol"},{"key":"36_CR109","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0006-2952(99)00335-4","volume":"59","author":"MH Pan","year":"2000","unstructured":"Pan MH, Lin-Shiau SY, Ho CT, Lin JH, Lin JK: Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3.-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol. 2000, 59: 357-67. 10.1016\/S0006-2952(99)00335-4.","journal-title":"Biochem Pharmacol"},{"key":"36_CR110","first-page":"3428","volume":"54","author":"ZY Wang","year":"1994","unstructured":"Wang ZY, Huang MT, Lou YR, Xie JG, Reuhl KR, Newmark HL, Ho CT, Yang CS, Conney AH: Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res. 1994, 54: 3428-35.","journal-title":"Cancer Res"},{"issue":"3","key":"36_CR111","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0026-895X(24)12615-6","volume":"60","author":"F Yang","year":"2001","unstructured":"Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW: The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol. 2001, 60 (3): 528-33.","journal-title":"Mol Pharmacol"},{"key":"36_CR112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/2004-00032.Aneja","volume":"10","author":"R Aneja","year":"2004","unstructured":"Aneja R, Hake P, Denenberg A, Burroughs T, Wong H, Zingarelli B: Epigallocatechin, a Green Tea Polyphenol, Attenuates Myocardial Ischemia Reperfusion Injury in Rats. Molecular Medicine. 2004, 10: 1-6.","journal-title":"Molecular Medicine"},{"key":"36_CR113","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.4049\/jimmunol.170.8.4335","volume":"170","author":"M Dona","year":"2003","unstructured":"Dona M, Dell'Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S: Neutrophil restraint by green tea: Inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol. 2003, 170: 4335-41.","journal-title":"J Immunol"},{"key":"36_CR114","doi-asserted-by":"publisher","first-page":"30574","DOI":"10.1074\/jbc.M202832200","volume":"277","author":"Y Levites","year":"2002","unstructured":"Levites Y, Amit T, Youdim MB, Mandel S: Involvement of protein kinase C activation and cell survival\/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem. 2002, 277: 30574-80. 10.1074\/jbc.M202832200.","journal-title":"J Biol Chem"},{"key":"36_CR115","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0006-2952(01)00813-9","volume":"63","author":"Y Levites","year":"2002","unstructured":"Levites Y, Youdim MB, Maor G, Mandel S: Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol. 2002, 63: 21-9. 10.1016\/S0006-2952(01)00813-9.","journal-title":"Biochem Pharmacol"},{"key":"36_CR116","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/jnci\/89.24.1881","volume":"89","author":"N Ahmad","year":"1997","unstructured":"Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H: Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst. 1997, 89: 1881-6. 10.1093\/jnci\/89.24.1881.","journal-title":"J Natl Cancer Inst"},{"key":"36_CR117","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1749-6632.2002.tb04678.x","volume":"973","author":"E Tedeschi","year":"2002","unstructured":"Tedeschi E, Suzuki H, Menegazzi M: Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. Ann N Y Acad Sci. 2002, 973: 435-7.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"36_CR118","doi-asserted-by":"publisher","first-page":"G954","DOI":"10.1152\/ajpgi.00302.2003","volume":"287","author":"JL Watson","year":"2004","unstructured":"Watson JL, Ansari S, Cameron H, Wang A, Akhtar M, McKay DM: Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4. Am J Physiol Gastrointest Liver Physiol. 2004, 287 (5): G954-61. 10.1152\/ajpgi.00302.2003. Epub 2004 Jul 1","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"36_CR119","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0952-3278(96)90028-9","volume":"54","author":"R Abbate","year":"1996","unstructured":"Abbate R, Gori AM, Martini F, Brunelli T, Filippini M, Francalanci I, Paniccia R, Prisco D, Gensini GF, Neri Serneri GG: n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production. Prostaglandins Leukot Essent Fatty Acids. 1996, 54 (6): 439-44. 10.1016\/S0952-3278(96)90028-9.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"36_CR120","first-page":"589","volume":"400B","author":"B Khalfoun","year":"1997","unstructured":"Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y: Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol. 1997, 400B: 589-97.","journal-title":"Adv Exp Med Biol"},{"key":"36_CR121","doi-asserted-by":"crossref","unstructured":"Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN: ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 106 (16): 2055-60. 10.1161\/01.CIR.0000034508.55617.65. 2002 Oct 15","DOI":"10.1161\/01.CIR.0000034508.55617.65"},{"key":"36_CR122","doi-asserted-by":"crossref","unstructured":"Kastelein JJ, de Groot E, Sankatsing R: Atherosclerosis measured by B-mode ultrasonography: effect of statin therapy on disease progression. Am J Med. 116 (Suppl 6A): 31S-36S. 2004 Mar 22","DOI":"10.1016\/j.amjmed.2004.02.009"},{"issue":"8","key":"36_CR123","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1210\/jc.85.8.2793","volume":"85","author":"H Koshiyama","year":"2000","unstructured":"Koshiyama H, Nakamura Y, Tanaka S, Minamikawa J: Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. J Clin Endocrinol Metab. 2000, 85 (8): 2793-2796. 10.1210\/jc.85.8.2793.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"36_CR124","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0021-9150(87)90263-2","volume":"67","author":"AS Daoud","year":"1987","unstructured":"Daoud AS, Frank AS, Jarmolych J, Fritz KE: The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on necrosis of atherosclerotic lesions. Atherosclerosis. 1987, 67 (1): 41-8. 10.1016\/0021-9150(87)90263-2.","journal-title":"Atherosclerosis"},{"key":"36_CR125","doi-asserted-by":"crossref","unstructured":"Maziere C, Conte MA, Maziere JC: Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radic Biol Med. 31 (11): 1334-40. 10.1016\/S0891-5849(01)00649-9. 2001 Dec 1","DOI":"10.1016\/S0891-5849(01)00649-9"},{"issue":"5","key":"36_CR126","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3346\/jkms.2004.19.5.656","volume":"19","author":"CS Lee","year":"2004","unstructured":"Lee CS, Kwon SJ, Na SY, Lim SP, Lee JH: Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits. J Korean Med Sci. 2004, 19 (5): 656-61.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"36_CR127","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.34.1.118","volume":"34","author":"Y Funakoshi","year":"1999","unstructured":"Funakoshi Y, Ichiki T, Ito K, Takeshita A: Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension. 1999, 34 (1): 118-25.","journal-title":"Hypertension"},{"issue":"4","key":"36_CR128","first-page":"675","volume":"48","author":"H Ruetten","year":"1997","unstructured":"Ruetten H, Thiemermann C: Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. J Physiol Pharmacol. 1997, 48 (4): 675-88.","journal-title":"J Physiol Pharmacol"},{"issue":"2","key":"36_CR129","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s003950050170","volume":"95","author":"M Browatzki","year":"2000","unstructured":"Browatzki M, Schmidt J, Kubler W, Kranzhofer R: Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells. Basic Res Cardiol. 2000, 95 (2): 98-105. 10.1007\/s003950050170.","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"36_CR130","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ymgme.2004.04.001","volume":"82","author":"JW Stephens","year":"2004","unstructured":"Stephens JW, Hurel SJ, Cooper JA, Acharya J, Miller GJ, Humphries SE: A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol Genet Metab. 2004, 82 (2): 180-6. 10.1016\/j.ymgme.2004.04.001.","journal-title":"Mol Genet Metab"},{"key":"36_CR131","doi-asserted-by":"crossref","unstructured":"Okamoto T, Yamagishi S, Inagaki Y, Amano S, Takeuchi M, Kikuchi S, Ohno S, Yoshimura A: Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro. Biochem Biophys Res Commun. 297 (2): 419-24. 10.1016\/S0006-291X(02)02218-0. 2002 Sep 20","DOI":"10.1016\/S0006-291X(02)02218-0"},{"issue":"6","key":"36_CR132","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0002-9440(10)63239-7","volume":"165","author":"S Yamagishi","year":"2004","unstructured":"Yamagishi S, Abe R, Inagaki Y, Nakamura K, Sugawara H, Inokuma D, Nakamura H, Shimizu T, Takeuchi M, Yoshimura A, Bucala R, Shimizu H, Imaizumi T: Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling. Am J Pathol. 2004, 165 (6): 1865-74.","journal-title":"Am J Pathol"},{"issue":"11","key":"36_CR133","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1007\/s001250100008","volume":"44","author":"EB Jude","year":"2001","unstructured":"Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, Boulton AJ: Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001, 44 (11): 2032-7. 10.1007\/s001250100008.","journal-title":"Diabetologia"},{"key":"36_CR134","doi-asserted-by":"crossref","unstructured":"A coronary primary prevention study of Scottish men aged 45\u201364 years: trial design. The West of Scotland Coronary Prevention Study Group. J Clin Epidemiol. 1992, 45 (8): 849-60. 10.1016\/0895-4356(92)90068-X.","DOI":"10.1016\/0895-4356(92)90068-X"},{"issue":"2","key":"36_CR135","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2005.05.009","volume":"184","author":"V Wong","year":"2006","unstructured":"Wong V, Stavar L, Szeto L, Uffelman K, Wang CH, Fantus IG, Lewis GF: Atorvastatin induces insulin sensitization in Zucker lean and fatty rats. Atherosclerosis. 2006, 184 (2): 348-55. 10.1016\/j.atherosclerosis.2005.05.009. Epub 2005 Jul 5","journal-title":"Atherosclerosis"},{"issue":"2","key":"36_CR136","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5551\/jat.12.77","volume":"12","author":"M Suzuki","year":"2005","unstructured":"Suzuki M, Kakuta H, Takahashi A, Shimano H, Tada-Iida K, Yokoo T, Kihara R, Yamada N: Effects of atorvastatin on glucose metabolism and insulin resistance in KK\/Ay mice. J Atheroscler Thromb. 2005, 12 (2): 77-84.","journal-title":"J Atheroscler Thromb"},{"issue":"6","key":"36_CR137","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/ajcn\/76.6.1191","volume":"76","author":"Sam J Bhathena","year":"2002","unstructured":"Bhathena Sam, Velasquez Manuel: Beneficial role of dietary phytoestrogens in obesity and diabetes. American Journal of Clinical Nutrition. 2002, 76 (6): 1191-1201.","journal-title":"American Journal of Clinical Nutrition"},{"key":"36_CR138","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2337\/diacare.25.10.1709","volume":"25","author":"V Jayagopal","year":"2002","unstructured":"Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL: Beneficial effects of soy phytoestrogen intake in postmenopausal women with Type 2 diabetes. Diabetes Care. 2002, 25: 1709-1714. 10.2337\/diacare.25.10.1709.","journal-title":"Diabetes Care"},{"key":"36_CR139","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/ajcn\/76.6.1191","volume":"76","author":"SJ Bhathena","year":"2002","unstructured":"Bhathena SJ, Velasquez MT: Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr. 2002, 76: 1191-1201.","journal-title":"Am J Clin Nutr"},{"key":"36_CR140","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/jn\/133.5.1238","volume":"133","author":"Mezei Orsolya","year":"2003","unstructured":"Orsolya Mezei, Banz* William, Steger* Richard, Peluso* Michael, Winters* Todd, Shay Neil: Soy Isoflavones Exert Antidiabetic and Hypolipidemic Effects through the PPAR Pathways in Obese Zucker Rats and Murine RAW 264.7 Cells. J Nutr. 2003, 133: 1238-1243.","journal-title":"J Nutr"},{"issue":"3","key":"36_CR141","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.mehy.2003.11.042","volume":"64","author":"MF McCarty","year":"2005","unstructured":"McCarty MF: Potential utility of natural polyphenols for reversing fat-induced insulin resistance. Med Hypotheses. 2005, 64 (3): 628-35. 10.1016\/j.mehy.2003.11.042.","journal-title":"Med Hypotheses"},{"issue":"5","key":"36_CR142","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1248\/bpb.20.507","volume":"20","author":"T Shimura","year":"1997","unstructured":"Shimura T, Miura T, Usami M, Ishihara E, Tanigawa K, Ishida H, Seino Y: Docosahexanoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM). Biol Pharm Bull. 1997, 20 (5): 507-10.","journal-title":"Biol Pharm Bull"},{"key":"36_CR143","volume-title":"The Biochemical Origin of Pain: How a new law and new drugs have led to a medical breakthrough in the treatment of Persistent pain","author":"S Omoigui","year":"2004","unstructured":"Omoigui S: The Biochemical Origin of Pain: How a new law and new drugs have led to a medical breakthrough in the treatment of Persistent pain. 2004, Hawthorne, California. State-of-the-Art Technologies Publishers"},{"key":"36_CR144","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650110113","volume":"11","author":"S Kotake","year":"1996","unstructured":"Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T, Kashiwazaki S: Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids form rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res. 1996, 11: 88-95.","journal-title":"J Bone Miner Res"},{"key":"36_CR145","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/art.1780310614","volume":"31","author":"F Houssiau","year":"1988","unstructured":"Houssiau F, Devoglaer JP, Van Damme J, Nagant de Deuxchaisnes C, Van Snick J: Interleukin 6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1988, 31: 784-788. 10.1002\/art.1780310614.","journal-title":"Arthritis Rheum"},{"key":"36_CR146","doi-asserted-by":"crossref","unstructured":"Veldman PH, Reynen HM, Arntz IE, Goris RJ: Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 342 (8878): 1012-6. 10.1016\/0140-6736(93)92877-V. 1993 Oct 23","DOI":"10.1016\/0140-6736(93)92877-V"},{"key":"36_CR147","doi-asserted-by":"crossref","unstructured":"Manolagas SC, Jilka RL: Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 332 (5): 305-11. 10.1056\/NEJM199502023320506. 1995 Feb 2","DOI":"10.1056\/NEJM199502023320506"},{"key":"36_CR148","doi-asserted-by":"publisher","first-page":"57S","DOI":"10.1016\/8756-3282(95)00179-H","volume":"17","author":"GD Roodman","year":"1995","unstructured":"Roodman GD: Osteoclast function in Paget's disease and multiple myeloma. Bone. 1995, 17: 57S-61S. 10.1016\/8756-3282(95)00179-H.","journal-title":"Bone"},{"key":"36_CR149","first-page":"370","volume":"147","author":"P Ravaud","year":"1996","unstructured":"Ravaud P, Thepot C, Auleley GR, Amor B: Imaging of multiple myeloma. Ann Med Interne [Paris]. 1996, 147: 370-5.","journal-title":"Ann Med Interne [Paris]"},{"key":"36_CR150","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0889-8588(05)70413-5","volume":"11","author":"G Teoh","year":"1997","unstructured":"Teoh G, Anderson KC: Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma. Hematol Oncol Clin North Am. 1997, 11: 27-42. 10.1016\/S0889-8588(05)70413-5.","journal-title":"Hematol Oncol Clin North Am"},{"key":"36_CR151","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0889-8588(05)70413-5","volume":"11","author":"G Teoh","year":"1997","unstructured":"Teoh G, Anderson KC: Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma. Hematol Oncol Clin North Am. 1997, 11: 27-42. 10.1016\/S0889-8588(05)70413-5.","journal-title":"Hematol Oncol Clin North Am"},{"key":"36_CR152","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.4049\/jimmunol.142.9.3134","volume":"142","author":"Tabibzadeh SS","year":"1989","unstructured":"SS Tabibzadeh, U Santhanam, PB Sehgal, LT May: Cytokine-induced production of IFN-\u03b22\/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17\u03b2. J Immunol. 1989, 142: 3134-3139.","journal-title":"J Immunol"},{"key":"36_CR153","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1532-5415.1995.tb07328.x","volume":"43","author":"DM Kania","year":"1995","unstructured":"Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB: Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriat Soc. 1995, 43: 236-239.","journal-title":"J Am Geriat Soc"},{"key":"36_CR154","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/jbmr.5650090614","volume":"9","author":"SH Ralston","year":"1994","unstructured":"Ralston SH: Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced Cytokine expression in post-menopausal osteoporosis. J Bone Miner Res. 1994, 9: 883-890.","journal-title":"J Bone Miner Res"},{"key":"36_CR155","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.4049\/jimmunol.150.12.5219","volume":"150","author":"RA Daynes","year":"1993","unstructured":"Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY: Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol. 1993, 150: 5219-5230.","journal-title":"J Immunol"},{"key":"36_CR156","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1073\/pnas.88.12.5134","volume":"88","author":"R Pacifici","year":"1991","unstructured":"Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV: Effect of surgical menopause and estrogen replacement on Cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA. 1991, 88: 5134-5138. 10.1073\/pnas.88.12.5134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR157","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/cs0830503","volume":"83","author":"G Pioli","year":"1992","unstructured":"Pioli G, Basini G, Pedtazzoni M, Musetti G, Ulietti V, Bresciani D, Villa P, Bacchi A, Hughes D, Russel M, Passeri M: Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood mononuclear cells after oophorectomy. Clin Sci. 1992, 83: 503-507.","journal-title":"Clin Sci"},{"key":"36_CR158","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI115668","volume":"89","author":"G Girasole","year":"1992","unstructured":"Girasole G, Jilka RL, Passeri F, Boswell S, Boder G, Williams DC, Manologas SC: 17\u03b2-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 1992, 89: 883-891.","journal-title":"J Clin Invest"},{"key":"36_CR159","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI115668","volume":"89","author":"G Girasole","year":"1992","unstructured":"Girasole G, Jilka RL, Passeri F, Boswell S, Boder G, Williams DC, Manologas SC: 17\u03b2-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens). J Clin Invest. 1992, 89: 883-891.","journal-title":"J Clin Invest"},{"key":"36_CR160","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1621100","volume":"257","author":"RL Jilka","year":"1992","unstructured":"Jilka RL, Hangoc C, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC: Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science. 1992, 257: 88-91. 10.1126\/science.1621100.","journal-title":"Science"},{"key":"36_CR161","volume-title":"The Biochemical Origin of Pain: How a new law and new drugs have led to a medical breakthrough in the treatment of Persistent pain","author":"S Omoigui","year":"2004","unstructured":"Omoigui S: The Biochemical Origin of Pain: How a new law and new drugs have led to a medical breakthrough in the treatment of Persistent pain. 2004, Hawthorne, California. State-of-the-Art Technologies Publishers"},{"issue":"2","key":"36_CR162","first-page":"219","volume":"61","author":"K Nakatsuka","year":"2003","unstructured":"Nakatsuka K: Development of bisphosphonates. Nippon Rinsho. 2003, 61 (2): 219-25.","journal-title":"Nippon Rinsho"},{"issue":"6","key":"36_CR163","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2174\/1566524023362104","volume":"2","author":"GA Rodan","year":"2002","unstructured":"Rodan GA, Reszka AA: Bisphosphonate mechanism of action. Curr Mol Med. 2002, 2 (6): 571-7. 10.2174\/1566524023362104.","journal-title":"Curr Mol Med"},{"issue":"1","key":"36_CR164","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11926-003-0085-6","volume":"5","author":"AA Reszka","year":"2003","unstructured":"Reszka AA, Rodan GA: Bisphosphonate mechanism of action. Curr Rheumatol Rep. 2003, 5 (1): 65-74.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"36_CR165","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00198-002-1323-x","volume":"14","author":"DC Bauer","year":"2003","unstructured":"Bauer DC: HMG CoA reductase inhibitors and the skeleton: a comprehensive review. Osteoporos Int. 2003, 14 (4): 273-82. 10.1007\/s00198-002-1323-x. Epub 2003 May 08","journal-title":"Osteoporos Int"},{"issue":"2","key":"36_CR166","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1385\/JCD:5:2:151","volume":"5","author":"HL Funkhouser","year":"2002","unstructured":"Funkhouser HL, Adera T, Adler RA: Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density. J Clin Densitom. 2002, 5 (2): 151-8. 10.1385\/JCD:5:2:151.","journal-title":"J Clin Densitom"},{"key":"36_CR167","doi-asserted-by":"crossref","unstructured":"Pasco JA, Kotowicz MA, Henry MJ, Sanders KM, Nicholson GC, Geelong Osteoporosis Study: Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study. Arch Intern Med. 162 (5): 537-40. 10.1001\/archinte.162.5.537. 2002 Mar 11","DOI":"10.1001\/archinte.162.5.537"},{"issue":"1","key":"36_CR168","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1359\/jbmr.2003.18.1.88","volume":"18","author":"A Staal","year":"2003","unstructured":"Staal A, Frith JC, French MH, Swartz J, Gungor T, Harrity TW, Tamasi J, Rogers MJ, Feyen JH: The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res. 2003, 18 (1): 88-96. 10.1359\/jbmr.2003.18.1.88.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"36_CR169","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1089\/jwh.2004.13.1000","volume":"13","author":"LS Harkness","year":"2004","unstructured":"Harkness LS, Fiedler K, Sehgal AR, Oravec D, Lerner E: Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Womens Health (Larchmt). 2004, 13 (9): 1000-7.","journal-title":"J Womens Health (Larchmt)"},{"issue":"10","key":"36_CR170","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1301\/nr.2003.oct.346-351","volume":"61","author":"A Cotter","year":"2003","unstructured":"Cotter A, Cashman KD: Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev. 2003, 61 (10): 346-51. 10.1301\/nr.2003.oct.346-351.","journal-title":"Nutr Rev"},{"issue":"7","key":"36_CR171","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1359\/jbmr.2003.18.7.1206","volume":"18","author":"D Sun","year":"2003","unstructured":"Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G: Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res. 2003, 18 (7): 1206-16. 10.1359\/jbmr.2003.18.7.1206.","journal-title":"J Bone Miner Res"},{"key":"36_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1322.001","volume":"1028","author":"C Caruso","year":"2004","unstructured":"Caruso C, Lio D, Cavallone L, Franceschi C: Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci. 2004, 1028: 1-13. 10.1196\/annals.1322.001.","journal-title":"Ann N Y Acad Sci"},{"key":"36_CR173","doi-asserted-by":"crossref","unstructured":"Wu KD, Orme LM, Shaughnessy J, Jacobson J, Barlogie B, Moore MA: Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood. 101 (12): 4982-9. 10.1182\/blood-2002-11-3451. 2003 Jun 15; Epub 2003 Feb 27","DOI":"10.1182\/blood-2002-11-3451"},{"key":"36_CR174","doi-asserted-by":"crossref","unstructured":"Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R: Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA. 100 (15): 9090-5. 10.1073\/pnas.1531903100. 2003 Jul 22; Epub 2003 Jul 02","DOI":"10.1073\/pnas.1531903100"},{"issue":"6","key":"36_CR175","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/1523-1747.ep12874666","volume":"94","author":"A Urbanski","year":"1990","unstructured":"Urbanski A, Schwarz T, Neuner P, Krutmann J, Kirnbauer R, Kock A, Luger TA: Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol. 1990, 94 (6): 808-11. 10.1111\/1523-1747.ep12874666.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"36_CR176","first-page":"943","volume":"16","author":"J Xia","year":"2005","unstructured":"Xia J, Song X, Bi Z, Chu W, Wan Y: UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro. Int J Mol Med. 2005, 16 (5): 943-50.","journal-title":"Int J Mol Med"},{"issue":"6","key":"36_CR177","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/archopht.123.6.774","volume":"123","author":"JM Seddon","year":"2005","unstructured":"Seddon JM, George S, Rosner B, Rifai N: Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol. 2005, 123 (6): 774-82. 10.1001\/archopht.123.6.774.","journal-title":"Arch Ophthalmol"},{"key":"36_CR178","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998, 102: 1369-1376.","journal-title":"J Clin Invest"},{"key":"36_CR179","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/08916939608995343","volume":"23","author":"M Linker-Israeli","year":"1996","unstructured":"Linker-Israeli M, DJ Wallace, JL Prehn, R Nand, L Li, JR Klinenberg: A greater variability in the 3' flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE). Autoimmunity. 1996, 23: 199-209.","journal-title":"Autoimmunity"},{"key":"36_CR180","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S8756-3282(97)00081-1","volume":"21","author":"R Murray","year":"1997","unstructured":"Murray R, F McGuigan, S Grant, D Reid, S Ralston: Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone. 1997, 21: 89-92. 10.1016\/S8756-3282(97)00081-1.","journal-title":"Bone"},{"key":"36_CR181","unstructured":"Dubey VS: Mevalonate-independent pathway of isoprenoids synthesis: A potential target in some human pathogens. Current science. 83 (6): 685-687. 25 September 2002"}],"container-title":["Immunity &amp; Ageing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4933-4-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-4933-4-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4933-4-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:30:26Z","timestamp":1736987426000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/1742-4933-4-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,20]]},"references-count":181,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1186\/1742-4933-4-1","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,20]]},"article-number":"1"}}